Rasch Measurement Theory (RMT) Analyses of the Huntington's Disease Everyday Functioning (Hi-DEF) to Evaluate Item Fit and Performance
- PMID: 39213085
- PMCID: PMC11492140
- DOI: 10.3233/JHD-240001
Rasch Measurement Theory (RMT) Analyses of the Huntington's Disease Everyday Functioning (Hi-DEF) to Evaluate Item Fit and Performance
Abstract
Background: The Huntington's Disease (HD) Everyday Functioning (Hi-DEF) is a new patient-reported outcome (PRO) instrument designed to measure the impact of cognitive impairment on daily functioning in the early stages of HD.
Objective: To assess the measurement properties and finalize item content of the Hi-DEF.
Methods: A cross-sectional, observational psychometric validation study was conducted among individuals with early stages of HD at 9 US centers of excellence. Rasch Measurement Theory (RMT) analysis of the initial draft version of the Hi-DEF (47 items) and subscales (i.e., 'Home', 'At work', 'Driving', and 'Communication') was conducted to examine measurement properties including sample-to-scale targeting, suitability of response scale (ordering of response thresholds), scale cohesiveness (item fit), local independence, and person fit.
Results: 151 participants (mean age 47 years (SD 12), 59% female) were included. Seven items were removed based on dependency and item fit. The remaining 40-item version of the Hi-DEF demonstrated good measurement properties. Across the four subscales, targeting ranged from 49-70% (72% full scale), reliability ascertained by person separation index ranged from 0.53-0.87 (0.92 full scale), response scales were ordered for 25-100% of items (75% full scale), 0-12% items displayed misfit (2% full scale), and 0-1% (2% full scale) item pairs displayed dependency.
Conclusions: Our study supports the psychometric integrity of the Hi-DEF as a reliable and valid new PRO instrument designed to assess the impact of cognitive impairment on daily functioning in the early stages of HD. Future work will evaluate the external validity and utility in clinical trial applications.
Keywords: Hi-DEF; Huntington’s disease; activities of daily living; executive function; patient-reported outcomes; psychometrics.
Conflict of interest statement
Jennifer Petrillo, Ruta Sawant, and Jason Johannesen are employees of Sage Therapeutics, and may have stock/stock options. Sarah Baradaran was an employee of Sage Therapeutics at the time the study was conducted and may have stock. Rebecca Rogers, Sophie Cleanthous, and Stefan Cano are employees of Modus Outcomes, a division of THREAD, which received payment from Sage Therapeutics to conduct this research. Emma Elliott is a former employee of Modus Outcomes (an employee of Modus Outcomes at the time this study was conducted). Logistical support was provided by Boston Strategic Partners, Inc. (funded by Sage Therapeutics).
Figures



Similar articles
-
Cognitive impairment in Huntington's disease and its impact on functioning: Concept elicitation and cognitive debriefing for the Huntington's Disease Everyday Functioning (Hi-DEF) scale.J Huntingtons Dis. 2024 Nov;13(4):511-522. doi: 10.1177/18796397241289044. Epub 2024 Oct 23. J Huntingtons Dis. 2024. PMID: 39973381
-
Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease.J Huntingtons Dis. 2025 Jul 22:18796397251358375. doi: 10.1177/18796397251358375. Online ahead of print. J Huntingtons Dis. 2025. PMID: 40692327
-
Rasch Analysis of the Listening Effort Questionnaire-Cochlear Implant.Ear Hear. 2021 Nov-Dec 01;42(6):1699-1711. doi: 10.1097/AUD.0000000000001059. Ear Hear. 2021. PMID: 33950866
-
Validation of the Dutch version of the Swallowing Quality-of-Life Questionnaire (DSWAL-QoL) and the adjusted DSWAL-QoL (aDSWAL-QoL) using item analysis with the Rasch model: a pilot study.Health Qual Life Outcomes. 2017 Apr 7;15(1):66. doi: 10.1186/s12955-017-0639-3. Health Qual Life Outcomes. 2017. PMID: 28388899 Free PMC article.
-
Development of a new Rasch-based scoring algorithm for the National Eye Institute Visual Functioning Questionnaire to improve its interpretability.Health Qual Life Outcomes. 2017 Aug 14;15(1):157. doi: 10.1186/s12955-017-0726-5. Health Qual Life Outcomes. 2017. PMID: 28807029 Free PMC article.
References
-
- McColgan P, Tabrizi SJ. Huntington’s disease: A clinical review. Eur J Neurol. 2018;25(1):24–34. - PubMed
-
- Yohrling G, Raimundo K, Crowell V, Lovecky D, Vetter L, Seeberger L. Prevalence of Huntington’s disease in the US (954). AAN Enterprises; 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical